Clinical Trial Update: Sacubitril/Valsartan in Left Ventricular Assist Device Recipients [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial evaluating sacubitril/valsartan in patients with heart failure who have a left ventricular assist device (LVAD).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Failure

Drugs mentioned

• Sacubitril/Valsartan (sacubitril/valsartan)

Snippet

Sponsor: University of Zagreb | Conditions: Heart Failure | Phase 4 | Status: UNKNOWN